(Q38236300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Tingting Tan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Yufei Xiang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Christopher Chang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

1 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

Clinical Reviews in Allergy & Immunology

11 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

234-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086642%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12016-014-8440-0

11 March 2020

exact match

0 references

cites work

Type 1 diabetes: etiology, immunology, and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Type I diabetes mellitus. A chronic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Mechanistic basis of immunotherapies for type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Is autoimmune diabetes caused by aberrant immune activity or defective suppression of physiological self-reactivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

21 January 2018

Autoimmunity in 2012.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Treg and CTLA-4: two intertwining pathways to immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Identification of a human Th1-like IFNγ-secreting Treg subtype deriving from effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Control of diabetes in NOD mice by suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

An essential role for Scurfin in CD4+CD25+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

FOXP3: genetic and epigenetic implications for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Regulatory T-cell therapy: is it ready for the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

How do CD4+CD25+ regulatory T cells control autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

CTLA-4 control over Foxp3+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-)two to tango

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Multiple immuno-regulatory defects in type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Lower frequency of CD62L(high) and higher frequency of TNFR2(+) Tregs are associated with inflammatory conditions in type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Uncoupling of proliferation and cytokines from suppression within the CD4+CD25+Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Inducible regulatory T cells (iTregs) from recent-onset type 1 diabetes subjects show increased in vitro suppression and higher ITCH levels compared with controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

The serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

CD4⁺ CD45RA⁻ FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Molecular antagonism and plasticity of regulatory and inflammatory T cell programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Analysis of islet inflammation in human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and β cell regeneration in a T1D model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

NKG2D blockade facilitates diabetes prevention by antigen-specific Tregs in a virus-induced model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

GAD treatment and insulin secretion in recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Long-lasting immune responses 4 years after GAD-alum treatment in children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Anti-CD3 clinical trials in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

Cutting Edge: Increased IL-17-Secreting T Cells in Children with New-Onset Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-014-8440-0

The Stimulation of Specific Suppressor T Cells in Genetic Non-Responder Mice by Linear Random Copolymers of L-Amino Acids

21 January 2018

1 reference

12 December 2020

No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes

1 reference

12 December 2020

NK cell trafficking in health and autoimmunity:a comprehensive review

1 reference

12 December 2020

CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice

1 reference

12 December 2020

Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes

1 reference

12 December 2020

Regulation of TGF-beta response during T cell activation is modulated by IL-10

1 reference

12 December 2020

Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes

1 reference

12 December 2020

CD4+CD25high regulatory T cells in human autoimmune diabetes

1 reference

12 December 2020

Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody

1 reference

12 December 2020

CD4 + CD25 + Cells Controlling a Pathogenic CD4 Response Inhibit Cytokine Differentiation, CXCR-3 Expression, and Tissue Invasion

1 reference

12 December 2020

Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes

1 reference

12 December 2020

Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo

1 reference

12 December 2020

Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes

1 reference

12 December 2020

Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study

1 reference

12 December 2020

Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes

1 reference

12 December 2020

Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes

1 reference

12 December 2020

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

1 reference

12 December 2020

Cell interactions in the induction of tolerance: the role of thymic lymphocytes

1 reference

12 December 2020

CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells

1 reference

12 December 2020

Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals

1 reference

12 December 2020

T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile

1 reference

12 December 2020